Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Keith

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 9, 2006
Advances in psychotropic formulationsSamuel Keith
Expert Review of Neurotherapeutics|December 24, 2008
Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectivenessSamuel Keith
Toxicology and Industrial Health|April 5, 2008
ATSDR evaluation of health effects of tungsten and relevance to public healthL Samuel Keith, Daphne B Moffett, Zemoria A Rosemond, et al.
Toxicology and Industrial Health|April 5, 2008
ATSDR evaluation of potential for human exposure to tungstenL Samuel Keith, David W Wohlers, Daphne B Moffett, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 12, 2003
Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatientsJuan R Bustillo, John Lauriello, Katherine Parker, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 25, 2020
Exploiting a Single-Crystal Environment to Minimize the Charge Noise on Qubits in SiliconLudwik Kranz, Samuel Keith Gorman, Brandur Thorgrimsson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 9, 2006
Advances in psychotropic formulationsSamuel Keith
Expert Review of Neurotherapeutics|December 24, 2008
Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectivenessSamuel Keith
Toxicology and Industrial Health|April 5, 2008
ATSDR evaluation of health effects of tungsten and relevance to public healthL Samuel Keith, Daphne B Moffett, Zemoria A Rosemond, et al.
Toxicology and Industrial Health|April 5, 2008
ATSDR evaluation of potential for human exposure to tungstenL Samuel Keith, David W Wohlers, Daphne B Moffett, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 12, 2003
Treatment of weight gain with fluoxetine in olanzapine-treated schizophrenic outpatientsJuan R Bustillo, John Lauriello, Katherine Parker, et al.
Advanced Materials (Deerfield Beach, Fla.)|August 25, 2020
Exploiting a Single-Crystal Environment to Minimize the Charge Noise on Qubits in SiliconLudwik Kranz, Samuel Keith Gorman, Brandur Thorgrimsson, et al.
Pageof 1